Status:
RECRUITING
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies
Lead Sponsor:
University of California, Davis
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
To study a novel biopsy needle system for performing transperineal prostate biopsy. Prostate biopsy remains the standard approach for prostate cancer detection. While pre-biopsy MRI allows for targeti...
Eligibility Criteria
Inclusion
- Patient older than age of 18 undergoing prostate biopsy
Exclusion
- Unable to consent
- Any comorbidity that, in the opinion of the investigator, could compromise protocol objectives
- Prisoners
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06907446
Start Date
May 1 2025
End Date
December 1 2027
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Departments of Urologic Oncology
Sacramento, California, United States, 95817